FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3190401 · Received June 26, 2013

Report

Report Number
1030489-2013-02535
Event Type
Injury
Date Received
June 26, 2013
Report Date
August 29, 2016
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Additional Manufacturer Narrative · 1

A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A STABILIZATION PROCEDURE AT T8-T9 RIGHT THORACOSCOPIC FUSION SURGERY USING RHBMP-2/ACS WITH A ZIMMER/SPINE TECH BAK CAGE. IT WAS REPORTED THAT IN (B)(6) 2006, THE PATIENT WAS SUBSEQUENTLY DIAGNOSED AS HAVING OSTEOPHYTE FORMATION (BONE GROWTH) ON THE RIGHT SIDE OF T8-T9. THIS OSTEOPHYTE CAUSED THE PATIENT PERSISTENT PAIN, BALANCE ISSUES, AND PARTIAL PARALYSIS. THE PATIENT HAS REQUIRED EXTENSIVE MEDICAL TREATMENT AND ADDITIONAL SURGERIES ON OR ABOUT (B)(6) 2006 AND (B)(6) 2007 TO REMOVE OSTEOPHYTES. REPORTEDLY, THE PATIENT HAS NEVER RECOVERED FROM HER SURGERY INVOLVING RHBMP-2/ACS, AND SHE CONTINUES TO HAVE DAILY SEVERE DISABLING PAIN THAT PREVENTS HER FROM PERFORMING MANY BASIC ACTIVITIES OF DAILY LIVING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
290824 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 44 YR Required Intervention